Search - tctmd.com

Displaying 101 - 120 of 147

Sort: Relevancy | Date

News Daily News

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

L.A. McKeown

February 25, 2015

Presentation

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Presenter: Marco Valgimigli

February 23, 2015

Presentation TCT 2014

Concept, Practice, and Outcomes of Deferred PCI in Thrombotic STEMI Culprit Lesions

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, Marco Valgimigli

September 16, 2014

Presentation TCT 2014

TCT 2: Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-Segment Elevation

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Josephine Warren

September 16, 2014

Presentation TCT 2014

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan

September 16, 2014

Presentation TCT 2014

Transradial Intervention in ACS: What are the Benefits (and Why)?

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Robert W. Yeh

September 16, 2014

Presentation TCT 2014

Improving STEMI Processes of Care, Choosing the Right Metrics, and Assessing Outcomes: Is It All About Door-to Balloon Time?

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Alice K. Jacobs

September 16, 2014

Presentation TCT 2014

Country by Country Variation in STEMI Management and Outcomes: Latest Stent for Life Data

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Petr Kala

September 16, 2014

Presentation TCT 2014

Is There a Role for Cilostazol with Contemporary DES?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Young-Hoon Jeong

September 14, 2014

Presentation TCT 2014

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Upendra Kaul

September 14, 2014

Presentation TCT 2014

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne

September 14, 2014

Presentation TCT 2014

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick

September 14, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

Presentation TCT 2014

Mechanical Issues with Current Metallic DES: Strut Fractures, Recoil, Longitudinal Stent Deformation, and More

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, John A. Ormiston

September 14, 2014

Presentation TCT 2014

Update on Neoatherosclerosis: Frequency, Diagnosis, and Treatment

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Soo-Jin Kang

September 14, 2014

Presentation TCT 2014

Time to Move to 3-6 Months Even in ACS!

Presenter: Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

News Conference News ESC 2014

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

Todd Neale

August 31, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

Advertisement

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

Zotarolimus-Eluting vs Bare-Metal Stents in Uncertain DES Candidates

Concept, Practice, and Outcomes of Deferred PCI in Thrombotic STEMI Culprit Lesions

TCT 2: Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-Segment Elevation

A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS

Transradial Intervention in ACS: What are the Benefits (and Why)?

Improving STEMI Processes of Care, Choosing the Right Metrics, and Assessing Outcomes: Is It All About Door-to Balloon Time?

Country by Country Variation in STEMI Management and Outcomes: Latest Stent for Life Data

Is There a Role for Cilostazol with Contemporary DES?

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease

Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere?

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Mechanical Issues with Current Metallic DES: Strut Fractures, Recoil, Longitudinal Stent Deformation, and More

Update on Neoatherosclerosis: Frequency, Diagnosis, and Treatment

Time to Move to 3-6 Months Even in ACS!

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Are GP IIb/IIIa Inhibitors Still Useful?

Algorithm Helps Identify MI Within 1 Hour in Patients with Acute Chest Pain

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content